Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Electromyography and Kinesiology : Official Journal of the International Society of Electrophysiological Kinesiology|September 12, 2002
Agonist-antagonist common drive during fatiguing knee extension efforts using surface electromyographyHugh Mullany, Mark O'Malley, Alan St Clair Gibson, et al.
IEEE Transactions on Bio-Medical Engineering|June 20, 2003
Automated processing of the single-lead electrocardiogram for the detection of obstructive sleep apnoeaPhilip de Chazal, Conor Heneghan, Elaine Sheridan, et al.
Neoplasia (New York, N.Y.)|January 12, 2013
Expression of CCL19 from oncolytic vaccinia enhances immunotherapeutic potential while maintaining oncolytic activityJun Li, Mark O'Malley, Padma Sampath, et al.
International Journal of Experimental Pathology|July 1, 2010
Establishment and characterization of a murine xenograft model of appendiceal mucinous adenocarcinomaArun A Mavanur, Vamsi Parimi, Mark O'Malley, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 18, 2002
The type 1 interleukin-1 receptor is essential for the efficient activation of microglia and the induction of multiple proinflammatory mediators in response to brain injuryAnirban Basu, J Kyle Krady, Mark O'Malley, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 27, 2011
Chemokine expression from oncolytic vaccinia virus enhances vaccine therapies of cancerJun Li, Mark O'Malley, Julie Urban, et al.
The Journal of Investigative Dermatology|September 25, 2020
Preclinical Evaluation of a Modified Herpes Simplex Virus Type 1 Vector Encoding Human TGM1 for the Treatment of Autosomal Recessive Congenital IchthyosisJohn C Freedman, Trevor J Parry, Peipei Zhang, et al.
Cell Host & Microbe|August 17, 2010
Alternate mechanisms of initial pattern recognition drive differential immune responses to related poxvirusesWilliam E O'Gorman, Padma Sampath, Erin F Simonds, et al.
Nature Medicine|March 29, 2022
In vivo topical gene therapy for recessive dystrophic epidermolysis bullosa: a phase 1 and 2 trialIrina Gurevich, Pooja Agarwal, PeiPei Zhang, et al.
Pageof 1